In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 155 for your search:
Drug:  azacitidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AZA-MDS-001, NCT01201811

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 60
Sponsor:
Protocol IDs: NCI-D81-018-590, DFCI-80035

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-013-686

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-AML-87, NCI-T86-0203D, T86-0203

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8820

7.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

8.

Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-9221, CALGB-9221

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-77AML318, SEG-77AML0103

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 and over
Sponsor:
Protocol IDs: UCLA-ALP-3

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 20
Sponsor: NCI
Protocol IDs: CCG-241

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor:
Protocol IDs: NCI-D82-061-724

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 50
Sponsor:
Protocol IDs: SEG-AML-81312R

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8101, POG-ANLL-2

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: DFCI-84010, NCI-T84-0245D, T84-0245

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 10 to 65
Sponsor:
Protocol IDs: EORTC-06821

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI
Protocol IDs: CCG-213

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: UKM-MRC-AML-9, NCI-T83-1410Q, T83-1410

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: NCI-D81-011-693, HOG-8130

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-251

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8821, POG-8821/22

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: NCI-D82-050-308, SJCRH-AML-80

24.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AZA PH GL 2003 CL 001, NCT00071799

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 120
Sponsor: Other
Protocol IDs: TUD-RELAZA-008, 2006-001040-31 (EudraCT Nr.), NCT00422890
1     
New Search